PFE (Pfizer Inc.) registra un BPA del 14,3 por ciento en el cuarto trimestre de 2025, las acciones suben un 1,25 por ciento en las operaciones regulares. - Señales de…

Pfizer marks 350 straight quarterly dividends with $0.43 payout

Pfizer Inc. Declares Second-Quarter Cash Dividend on Common Stock for 2026, Payable June 12, 2026

Pfizer Inc. $PFE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Pfizer Could Surprise Again This Earnings Season (Preview) (NYSE:PFE)

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Lyme Disease Vaccine Shows Over 70 Percent Efficacy

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Inc. (PFE) – Padcev Combination Therapy Receives FDA Priority Review for Expanded Bladder Cancer Indication - FCF Yield

Pfizer Inc. (PFE) – Padcev Combination Therapy Receives FDA Priority Review for Expanded Bladder Cancer Indication - Global Trading Community

Pfizer Inc. (PFE) - El precedente de fusiones y adquisiciones en oncología señala al sector al alza en medio de las conversaciones sobre la adquisición de Kelonia por parte de…

Pfizer Inc. (PFE) - Oncology M&A Precedent Signals Sector Upside Amid Eli Lilly’s Kelonia Acquisition Talks

Pfizer brings 40-plus cancer studies and 3 late-breakers to ASCO

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026